8-KEarnings & ResultsExhibits & Filings

BRISTOL MYERS SQUIBB CO 8-K Report, Financial Results (Apr 24, 2008)

Filed April 24, 2008For Securities:BMYCELG-RIBMYMP

Summary

Bristol-Myers Squibb Company (BMY) filed an 8-K on April 24, 2008, to announce its first-quarter 2008 financial results. The filing primarily serves to incorporate by reference a press release detailing these results and additional supplemental information available on the company's website. Investors looking for specific financial performance metrics, such as revenue, earnings per share, and any forward-looking guidance, would need to consult the referenced press release (Exhibit 99.1) and supplemental data (Exhibit 99.2).

Key Highlights

  • 1BMY filed an 8-K on April 24, 2008, reporting on its Q1 2008 financial results.
  • 2The primary purpose of this filing is to furnish a press release announcing the Q1 2008 financial results.
  • 3The press release is included as Exhibit 99.1.
  • 4Additional supplemental financial information is also furnished as Exhibit 99.2, available on the company's website.
  • 5Investors are directed to the referenced exhibits for detailed financial performance and operational data for the first quarter of 2008.
  • 6The filing does not contain new substantive disclosures within the 8-K body itself but references external documents for results.

Frequently Asked Questions

The main purpose of this 8-K filing is to officially report Bristol-Myers Squibb Company's financial results for the first quarter of 2008. It serves to make the press release and supplemental financial information publicly available through the SEC filing system.

The detailed financial results are not directly included in the body of the 8-K. Investors need to refer to Exhibit 99.1, which is the press release dated April 24, 2008, and Exhibit 99.2, which contains supplemental information found on the company's website (www.bms.com).

This particular 8-K filing is focused solely on the reporting of financial results. Any strategic announcements, updates, or forward-looking guidance would be contained within the referenced press release (Exhibit 99.1) and supplemental information (Exhibit 99.2), not within the 8-K document itself.